Bioquell PLC Trading Statement (6221S)
July 10 2015 - 2:00AM
UK Regulatory
TIDMBQE
RNS Number : 6221S
Bioquell PLC
10 July 2015
10 July, 2015
Bioquell PLC
Trading Update
Bioquell PLC ("Bioquell") (LSE symbol: BQE) - provider of
specialist microbiological control technologies to the
international Healthcare, Life Sciences & Defence markets today
announces an update on its trading performance for the six months
ended 30 June 2015.
Trading was in line with the Board's expectations.
We estimate that revenues for the Group's continuing activities
(the Bio division) for the six months ended 30 June 2015, will be
approximately GBP12.5 million (H1 2014: GBP12.3 million), an
increase in the period of some 2%.
The Company had net cash of GBP47.7 million at 30 June 2015, of
which GBP1.4m was used to pay the 2014 final dividend on 2
July.
The strategic review announced on 18 May 2015 is ongoing and
there is no further update at this stage.
The interim results for the six months ended 30 June, 2015 are
expected to be announced on 26 August, 2015.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTEAEXNEDKSEFF
Bioquell (LSE:BQE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bioquell (LSE:BQE)
Historical Stock Chart
From Sep 2023 to Sep 2024